An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
Status:
Terminated
Trial end date:
2012-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the pharmacodynamic effect on reflux parameters
of SPD557 tablets (0.5 mg t.i.d., on top of PPI treatment) in patients with Gastroesophageal
Reflux Disease (GERD) with persistent symptoms despite taking a stable dose of proton pump
inhibitors. Additionally the effect on symptoms will be explored and safety and tolerability
will be evaluated.